NurExone Biologic Inc. (TSXV:NRX)
Canada
· Delayed Price · Currency is CAD 0.7700
+0.0100 (1.32%)
Aug 15, 2025, 4:00 PM EDT
NurExone Biologic Market Cap
NurExone Biologic has a market cap or net worth of CAD 61.61 million as of August 15, 2025. Its market cap has increased by 45.60% in one year.
Market Cap
61.61M
Enterprise Value
60.81M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.77
Market Cap Chart
Since June 23, 2022, NurExone Biologic's market cap has increased from 33.48M to 61.61M, an increase of 83.99%. That is a compound annual growth rate of 21.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 60.81M | 38.34% |
| Dec 31, 2024 | 43.95M | 208.80% |
| Dec 28, 2023 | 14.23M | -14.84% |
| Dec 22, 2022 | 16.71M | -50.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 3.23B |
| Green Thumb Industries | 2.83B |
| Trulieve Cannabis | 2.38B |
| Sienna Senior Living | 1.71B |
| dentalcorp Holdings | 1.60B |
| Cronos Group | 1.39B |
| WELL Health Technologies | 1.27B |
| Extendicare | 1.13B |